Jinyu Bio-technology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	1,338	1,343	1,225	1,508	1,485	1,754
Other Revenue	53.76	53.76	30.13	89.92	43.97	22.64
Revenue	1,391	1,396	1,255	1,598	1,529	1,776
Revenue Growth (YoY)	10.50%	11.23%	-21.45%	4.55%	-13.94%	12.29%
Cost of Revenue	666.36	665.07	597.17	668.1	697.3	688.81
Gross Profit	724.94	731.35	658.29	930.13	831.37	1,088
Selling, General & Admin	523.98	525	432.34	491.55	421.77	501.9
Research & Development	112.01	131.09	136.82	143.47	133.78	165.94
Other Operating Expenses	15.05	23.36	21.83	23.14	22.26	24.5
Operating Expenses	699.21	727.63	621.1	681.43	579.36	693.32
Operating Income	25.73	3.72	37.19	248.7	252.01	394.19
Interest Expense	-0.47	-0.47	-5.5	-0.05	-4.81	-0.04
Interest & Investment Income	37.19	51.17	55.36	56.52	50.91	47.57
Currency Exchange Gain (Loss)	-0.43	-0.43	0.05	-0.02	0.08	-0.05
Other Non Operating Income (Expenses)	-10.37	-2.85	-0.58	0.15	0.21	-0.76
EBT Excluding Unusual Items	51.65	51.14	86.52	305.28	298.39	440.91
Impairment of Goodwill	-	-	-3.21	-18.08	-65.02	-39.75
Gain (Loss) on Sale of Investments	-5.64	-4.01	-9.49	-7.78	-9.81	-3.22
Gain (Loss) on Sale of Assets	8.44	8.38	2.58	-0.04	-0.04	-2.31
Asset Writedown	-1.13	-2.91	-11.11	-5.34	-1.54	-1.99
Other Unusual Items	52.02	52.02	59.63	41.78	23.61	19.65
Pretax Income	105.34	104.62	124.91	315.83	245.58	413.27
Income Tax Expense	5.34	9.11	20.76	38.73	45.46	24.27
Earnings From Continuing Operations	100	95.51	104.15	277.1	200.12	389.01
Minority Interest in Earnings	4.27	4.61	4.83	6.53	10.54	-6.72
Net Income	104.27	100.11	108.99	283.63	210.66	382.29
Net Income to Common	104.27	100.11	108.99	283.63	210.66	382.29
Net Income Growth	30.54%	-8.14%	-61.58%	34.64%	-44.90%	-5.89%
Shares Outstanding (Basic)	1,127	1,112	1,090	1,091	1,109	1,124
Shares Outstanding (Diluted)	1,127	1,112	1,090	1,091	1,109	1,124
Shares Change (YoY)	2.56%	2.06%	-0.10%	-1.61%	-1.39%	-0.35%
EPS (Basic)	0.09	0.09	0.10	0.26	0.19	0.34
EPS (Diluted)	0.09	0.09	0.10	0.26	0.19	0.34
EPS Growth	27.27%	-10.00%	-61.54%	36.84%	-44.12%	-5.56%
Free Cash Flow	155.42	194.69	199.89	141.67	154.54	160.4
Free Cash Flow Per Share	0.14	0.17	0.18	0.13	0.14	0.14
Dividend Per Share	0.037	0.037	0.030	0.080	0.060	0.110
Dividend Growth	23.33%	23.33%	-62.50%	33.33%	-45.45%	-8.33%
Gross Margin	52.11%	52.37%	52.43%	58.20%	54.38%	61.22%
Operating Margin	1.85%	0.27%	2.96%	15.56%	16.49%	22.19%
Profit Margin	7.50%	7.17%	8.68%	17.75%	13.78%	21.52%
Free Cash Flow Margin	11.17%	13.94%	15.92%	8.86%	10.11%	9.03%
EBITDA	286.56	255.42	252.37	437.17	450.92	585.17
EBITDA Margin	20.60%	18.29%	20.10%	27.35%	29.50%	32.94%
D&A For EBITDA	260.83	251.7	215.18	188.47	198.91	190.98
EBIT	25.73	3.72	37.19	248.7	252.01	394.19
EBIT Margin	1.85%	0.27%	2.96%	15.56%	16.48%	22.19%
Effective Tax Rate	5.07%	8.71%	16.62%	12.26%	18.51%	5.87%
Revenue as Reported	1,396	1,396	1,255	1,598	1,529	1,776
Advertising Expenses	-	205.95	162.42	179.06	166.38	241.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.